Pharmacokinetics Services Market Size, Share, And Growth Report 2032

Pharmacokinetics Services Market: Size

The global Pharmacokinetics Services Market size was worth around USD 1629.76 million in 2023 and is predicted to grow to around USD 2996.25 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.00% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Pharmacokinetics Services Market on a global and regional level.

Request Free Sample

Pharmacokinetics Services Market: Overview

Pharmacokinetics (PK) deals with study of absorption, distribution, metabolism and excretion of drug substance in a living organism. The substance can be any chemical xenobiotic including biopharmaceutical drug, food additives, pharmaceutical drugs, cosmetics, pesticides etc. The detailed mechanism of absorption and chemical metabolism of administered drug substance is done to evaluate its fate from the time of administration to complete elimination from the body. Pharmacokinetics study involves study of how an organism reacts to the administered drug whereas pharmacodynamics study is how drug affects the organism. Pharmacokinetics and pharmacodynamics studies play important role in determining the dosing, adverse effects and potential therapeutic effects.

The demand for pharmacokinetics services market is driven by increasing attrition rate of therapeutic drugs in clinical trials as a result of poor pharmacokinetics. To reduce the risk of drug attrition in advanced phases of clinical trials, researchers focus on investigating pharmacokinetics studies at each developmental stage. Pharmacokinetics studies allow early detection of potential challenges that may occur during drug development stages and thus help determine modifications required and development strategies. Also, need for rapid and efficient preclinical studies and stringent regulatory requirements have propelled the pharmacokinetics services market growth. Different drug candidate reacts differently and different protocols need to be set for PK studies which is a time consuming process and is expensive. Thus, high cost of pharmacokinetics studies may hamper the market growth of the pharmacokinetics services market over the forecast period. Emerging nations such as India and China are expected to open new growth opportunities for pharmacokinetics service providers over the forecast period.

Global Pharmacokinetics Services Market: Segmentation

The study provides a crucial view on the pharmacokinetics services by segmenting the market based on drug type and region. All the segments of pharmacokinetics services market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on drug type, global pharmacokinetics services market is bifurcated into large molecule pharmacokinetics services and small molecule pharmacokinetics services. Small molecule PK services focus on small molecular weight drugs absorption, metabolism and excretion studies using spectroscopic assays and chromatography. Large molecule PH studies involve protein quantification and peptide interaction of large molecular weight molecules. The small molecule segment accounted for largest market share in 2023 whereas large molecule segment is expected to witness highest growth during the forecast period.

Pharmacokinetics Services Market: Report Scope

Global Pharmacokinetics Services Market: Regional Analysis

North America represents developed regional market for pharmacokinetics services. Presence of developed R&D infrastructure, presence of established pharmaceutical and biopharmaceutical companies, increasing clinical trial registrations, technological advancements are major factors driving the market growth in this region. Europe was second leading market in 2023. Increasing drug development spending, collaborations of drug manufacturers with clinical research organizations are expected to propel market growth in this region. Latin America is will see noticeable growth during the forecast period. Asia Pacific is estimated to be rapidly growing regional market for pharmacokinetics services. Focus of major CROs, pharmaceutical and biopharmaceutical companies on growth opportunities in emerging markets, and potential business expansion are factors that are expected to boost market growth in Asia Pacific. Middle East and Africa will register sluggish growth over the forecast period due to poor R&D infrastructure.

Pharmacokinetics Services Market: Competitive Players

• Ertara
• L.P.
• Evotec AG
• Shanghai Medicilon Inc.
• GVK Biosciences Private Limited
• Pharmaceutical Drug type Development
• Pacific BioLabs
• Charles River Laboratories International
• Eurofins Scientific
• PAREXEL International Corporation
• Frontage Labs
• Creative Bioarray
• LGC Limited
• SGS SA among others.

The report segment of global pharmacokinetics services market as follows:

Global Pharmacokinetics Services Market: Drug type

• Small Molecules Pharmacokinetics Services
• Large Molecules Pharmacokinetics Services

Global Pharmacokinetics Services Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa